{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:56:42Z","timestamp":1790837802264,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"DOI":"10.1038\/s41431-026-02249-w","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:08:05Z","timestamp":1790834885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insertion or deletion variants in TAF15 exon 15 are genetic factors impacting the prognosis of amyotrophic lateral sclerosis in a Japanese cohort"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-5985","authenticated-orcid":false,"given":"Yuya","family":"Hatano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9915-8665","authenticated-orcid":false,"given":"Tomohiko","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1485-0703","authenticated-orcid":false,"given":"Mari","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Hirokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Yokoseki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4244-0277","authenticated-orcid":false,"given":"Akiyoshi","family":"Kakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3354-5472","authenticated-orcid":false,"given":"Osamu","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2249_CR1","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","volume":"344","author":"LP Rowland","year":"2001","unstructured":"Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688\u20131700.","journal-title":"N Engl J Med"},{"key":"2249_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrneurol.2016.182","volume":"13","author":"A Al-Chalabi","year":"2017","unstructured":"Al-Chalabi A, van den Berg LH, Veldink J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat Rev Neurol. 2017;13:96\u2013104. https:\/\/doi.org\/10.1038\/nrneurol.2016.182.","journal-title":"Nat Rev Neurol"},{"key":"2249_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00401-017-1785-8","volume":"135","author":"N Bakkar","year":"2018","unstructured":"Bakkar N, Kovalik T, Lorenzini I, Spangler S, Lacoste A, Sponaugle K, et al. Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:227\u201347. https:\/\/doi.org\/10.1007\/s00401-017-1785-8.","journal-title":"Acta Neuropathol"},{"key":"2249_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","volume":"17","author":"R Chia","year":"2018","unstructured":"Chia R, Chio A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17:94\u2013102. https:\/\/doi.org\/10.1016\/S1474-4422(17)30401-5.","journal-title":"Lancet Neurol"},{"key":"2249_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/jnnp-2017-316820","volume":"89","author":"O Dols-Icardo","year":"2018","unstructured":"Dols-Icardo O, Garc\u00eda-Redondo A, Rojas-Garc\u00eda R, Borrego-Hern\u00e1ndez D, Ill\u00e1n-Gala I, Mu\u00f1oz-Blanco JL, et al. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the C9orf72 expansion mutation. J Neurol, Neurosurg Psychiatry. 2018;89:162\u20138.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"2249_CR6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/jnnp-2017-317611","volume":"89","author":"K Muller","year":"2018","unstructured":"Muller K, Brenner D, Weydt P, Meyer T, Grehl T, Petri S, et al. Comprehensive analysis of the mutation spectrum in 301 German ALS families. J Neurol Neurosurg Psychiatry. 2018;89:817\u201327. https:\/\/doi.org\/10.1136\/jnnp-2017-317611.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2249_CR7","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1038\/s41593-019-0530-0","volume":"22","author":"SMK Farhan","year":"2019","unstructured":"Farhan SMK, Howrigan DP, Abbott LE, Klim JR, Topp SD, Byrnes AE, et al. Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein. Nat Neurosci. 2019;22:1966\u201374. https:\/\/doi.org\/10.1038\/s41593-019-0530-0.","journal-title":"Nat Neurosci"},{"key":"2249_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ana.24306","volume":"77","author":"J Cady","year":"2015","unstructured":"Cady J, Allred P, Bali T, Pestronk A, Goate A, Miller TM, et al. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann Neurol. 2015;77:100\u201313. https:\/\/doi.org\/10.1002\/ana.24306.","journal-title":"Ann Neurol"},{"key":"2249_CR9","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1136\/jmedgenet-2013-101795","volume":"50","author":"KP Kenna","year":"2013","unstructured":"Kenna KP, McLaughlin RL, Byrne S, Elamin M, Heverin M, Kenny EM, et al. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J Med Genet. 2013;50:776\u201383. https:\/\/doi.org\/10.1136\/jmedgenet-2013-101795.","journal-title":"J Med Genet"},{"key":"2249_CR10","doi-asserted-by":"publisher","unstructured":"Nakamura R, Sone J, Atsuta N, Tohnai G, Watanabe H, Yokoi D, et al. Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. Neurobiol Aging. 2016;39:219 .e211\u2013218. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.11.030.","DOI":"10.1016\/j.neurobiolaging.2015.11.030"},{"key":"2249_CR11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/jnnp-2018-318568","volume":"90","author":"H Naruse","year":"2019","unstructured":"Naruse H, Ishiura H, Mitsui J, Takahashi Y, Matsukawa T, Tanaka M, et al. Burden of rare variants in causative genes for amyotrophic lateral sclerosis (ALS) accelerates age at onset of ALS. J Neurol Neurosurg Psychiatry. 2019;90:537\u201342. https:\/\/doi.org\/10.1136\/jnnp-2018-318568.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2249_CR12","doi-asserted-by":"publisher","unstructured":"Pang SY, Hsu JS, Teo KC, Li Y, Kung MHW, Cheah KSE, et al. Burden of rare variants in ALS genes influences survival in familial and sporadic ALS. Neurobiol Aging. 2017;58:238 .e239\u2013238 .e215. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.06.007.","DOI":"10.1016\/j.neurobiolaging.2017.06.007"},{"key":"2249_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","volume":"10","author":"A Chio","year":"2009","unstructured":"Chio A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10:310\u201323. https:\/\/doi.org\/10.3109\/17482960802566824.","journal-title":"Amyotroph Lateral Scler"},{"key":"2249_CR14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","volume":"17","author":"HJ Westeneng","year":"2018","unstructured":"Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423\u201333. https:\/\/doi.org\/10.1016\/S1474-4422(18)30089-9.","journal-title":"Lancet Neurol"},{"key":"2249_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/jnnp-2012-303507","volume":"84","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, McMillan CT, Brettschneider J, Libon DJ, Powers J, Rascovsky K, et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;84:163\u20139. https:\/\/doi.org\/10.1136\/jnnp-2012-303507.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2249_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","volume":"603","author":"XR Ma","year":"2022","unstructured":"Ma XR, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F, et al. TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature. 2022;603:124\u201330. https:\/\/doi.org\/10.1038\/s41586-022-04424-7.","journal-title":"Nature"},{"key":"2249_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1136\/jnnp-2022-330504","volume":"94","author":"SW Willemse","year":"2023","unstructured":"Willemse SW, Harley P, van Eijk RPA, Demaegd KC, Zelina P, Pasterkamp RJ, et al. UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic target. J Neurol Neurosurg Psychiatry. 2023;94:649\u201356. https:\/\/doi.org\/10.1136\/jnnp-2022-330504.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2249_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-024-02026-y","volume":"17","author":"T Ishihara","year":"2024","unstructured":"Ishihara T, Koyama A, Atsuta N, Tada M, Toyoda S, Kashiwagi K, et al. SMN2 gene copy number affects the incidence and prognosis of motor neuron diseases in Japan. BMC Med Genomics. 2024;17:263. https:\/\/doi.org\/10.1186\/s12920-024-02026-y.","journal-title":"BMC Med Genomics"},{"key":"2249_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron D. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord. 2000;1:293\u20139. https:\/\/doi.org\/10.1080\/146608200300079536.","journal-title":"Amyotroph Lateral Scler Other Mot Neuron Disord"},{"key":"2249_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.clinph.2007.09.143","volume":"119","author":"M de Carvalho","year":"2008","unstructured":"de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497\u2013503. https:\/\/doi.org\/10.1016\/j.clinph.2007.09.143.","journal-title":"Clin Neurophysiol"},{"key":"2249_CR21","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s10072-021-05465-y","volume":"43","author":"K Matsuzono","year":"2022","unstructured":"Matsuzono K, Suzuki M, Miura K, Ozawa T, Mashiko T, Koide R, et al. Higher incidence of cervical spinal cord compression in amyotrophic lateral sclerosis: a single-institute cohort study. Neurol Sci. 2022;43:1079\u201386. https:\/\/doi.org\/10.1007\/s10072-021-05465-y.","journal-title":"Neurol Sci"},{"key":"2249_CR22","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602\u201311. https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.093.","journal-title":"Biochem Biophys Res Commun"},{"key":"2249_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130\u20133. https:\/\/doi.org\/10.1126\/science.1134108.","journal-title":"Science"},{"key":"2249_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40478-016-0335-2","volume":"4","author":"R Takeuchi","year":"2016","unstructured":"Takeuchi R, Tada M, Shiga A, Toyoshima Y, Konno T, Sato T, et al. Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes. Acta Neuropathol Commun. 2016;4:61. https:\/\/doi.org\/10.1186\/s40478-016-0335-2.","journal-title":"Acta Neuropathol Commun"},{"key":"2249_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41593-021-01006-0","volume":"25","author":"EG Baxi","year":"2022","unstructured":"Baxi EG, Thompson T, Li J, Kaye JA, Lim RG, Wu J, et al. Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines. Nat Neurosci. 2022;25:226\u201337. https:\/\/doi.org\/10.1038\/s41593-021-01006-0.","journal-title":"Nat Neurosci"},{"key":"2249_CR26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1136\/jnnp-2012-302272","volume":"84","author":"T Konno","year":"2013","unstructured":"Konno T, Shiga A, Tsujino A, Sugai A, Kato T, Kanai K, et al. Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72. J Neurol Neurosurg Psychiatry. 2013;84:398\u2013401. https:\/\/doi.org\/10.1136\/jnnp-2012-302272.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2249_CR27","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","volume":"139","author":"PD Stenson","year":"2020","unstructured":"Stenson PD, Mort M, Ball EV, Chapman M, Evans K, Azevedo L, et al. The Human Gene Mutation Database (HGMD((R))): optimizing its use in a clinical diagnostic or research setting. Hum Genet. 2020;139:1197\u2013207. https:\/\/doi.org\/10.1007\/s00439-020-02199-3.","journal-title":"Hum Genet"},{"key":"2249_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201323.","journal-title":"Genet Med"},{"key":"2249_CR29","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","volume":"109","author":"V Pejaver","year":"2022","unstructured":"Pejaver V, Byrne AB, Feng BJ, Pagel KA, Mooney SD, Karchin R, et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria. Am J Hum Genet. 2022;109:2163\u201377. https:\/\/doi.org\/10.1016\/j.ajhg.2022.10.013.","journal-title":"Am J Hum Genet"},{"key":"2249_CR30","doi-asserted-by":"publisher","first-page":"e1007028","DOI":"10.1371\/journal.pcbi.1007028","volume":"15","author":"J-M Choi","year":"2019","unstructured":"Choi J-M, Dar F, Pappu RV. LASSI: A lattice model for simulating phase transitions of multivalent proteins. PLoS Comput Biol. 2019;15:e1007028.","journal-title":"PLoS Comput Biol"},{"key":"2249_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26733-7","volume":"12","author":"I Alshareedah","year":"2021","unstructured":"Alshareedah I, Moosa M, Pham M, Potoyan D, Banerjee P. Programmable viscoelasticity in protein-RNA condensates with disordered sticker-spacer polypeptides. Nat Commun. 2021;12:6620.","journal-title":"Nat Commun"},{"key":"2249_CR32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109967118","volume":"118","author":"FM Kelley","year":"2021","unstructured":"Kelley FM, Favetta B, Regy RM, Mittal J, Schuster BS. Amphiphilic proteins coassemble into multiphasic condensates and act as biomolecular surfactants. Proc Natl Acad Sci. 2021;118:e2109967118.","journal-title":"Proc Natl Acad Sci"},{"key":"2249_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1748","volume":"14","author":"MN Chowdhury","year":"2023","unstructured":"Chowdhury MN, Jin H. The RGG motif proteins: interactions, functions, and regulations. Wiley Interdiscip Rev: RNA. 2023;14:e1748.","journal-title":"Wiley Interdiscip Rev: RNA"},{"key":"2249_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/pro.3354","volume":"27","author":"KKC Li","year":"2018","unstructured":"Li KKC, Chau BL, Lee KAW. Differential interaction of PRMT1 with RGG-boxes of the FET family proteins EWS and TAF15. Protein Sci. 2018;27:633\u201342. https:\/\/doi.org\/10.1002\/pro.3354.","journal-title":"Protein Sci"},{"key":"2249_CR35","doi-asserted-by":"publisher","first-page":"12593","DOI":"10.1093\/nar\/gkaa1099","volume":"48","author":"RM Regy","year":"2020","unstructured":"Regy RM, Dignon GL, Zheng W, Kim YC, Mittal J. Sequence dependent phase separation of protein-polynucleotide mixtures elucidated using molecular simulations. Nucleic Acids Res. 2020;48:12593\u2013603.","journal-title":"Nucleic Acids Res"},{"key":"2249_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00401-008-0385-z","volume":"116","author":"Y Nishihira","year":"2008","unstructured":"Nishihira Y, Tan CF, Onodera O, Toyoshima Y, Yamada M, Morita T, et al. Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol. 2008;116:169\u201382. https:\/\/doi.org\/10.1007\/s00401-008-0385-z.","journal-title":"Acta Neuropathol"},{"key":"2249_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40478-021-01202-w","volume":"9","author":"M Sainouchi","year":"2021","unstructured":"Sainouchi M, Hatano Y, Tada M, Ishihara T, Ando S, Kato T, et al. A novel splicing variant of ANXA11 in a patient with amyotrophic lateral sclerosis: histologic and biochemical features. Acta Neuropathol Commun. 2021;9:106. https:\/\/doi.org\/10.1186\/s40478-021-01202-w.","journal-title":"Acta Neuropathol Commun"},{"key":"2249_CR38","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jmedgenet-2021-107965","volume":"59","author":"YP Chen","year":"2022","unstructured":"Chen YP, Yu SH, Wei QQ, Cao B, Gu XJ, Chen XP, et al. Role of genetics in amyotrophic lateral sclerosis: a large cohort study in Chinese mainland population. J Med Genet. 2022;59:840\u20139. https:\/\/doi.org\/10.1136\/jmedgenet-2021-107965.","journal-title":"J Med Genet"},{"key":"2249_CR39","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/archneurol.2011.250","volume":"68","author":"F Fecto","year":"2011","unstructured":"Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68:1440\u20136. https:\/\/doi.org\/10.1001\/archneurol.2011.250.","journal-title":"Arch Neurol"},{"key":"2249_CR40","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00401-013-1150-5","volume":"126","author":"H Shimizu","year":"2013","unstructured":"Shimizu H, Toyoshima Y, Shiga A, Yokoseki A, Arakawa K, Sekine Y, et al. Sporadic ALS with compound heterozygous mutations in the SQSTM1 gene. Acta Neuropathol. 2013;126:453\u20139. https:\/\/doi.org\/10.1007\/s00401-013-1150-5.","journal-title":"Acta Neuropathol"},{"key":"2249_CR41","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaa3650","volume":"347","author":"ET Cirulli","year":"2015","unstructured":"Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436\u201341. https:\/\/doi.org\/10.1126\/science.aaa3650.","journal-title":"Science"},{"key":"2249_CR42","doi-asserted-by":"crossref","unstructured":"Tohnai G, Nakamura R, Sone J, Nakatochi M, Yokoi D, Katsuno M, et al. Frequency and characteristics of the TBK1 gene variants in Japanese patients with sporadic amyotrophic lateral sclerosis. Neurobiol aging. 2018;64:158.e115\u2013158.e119.","DOI":"10.1016\/j.neurobiolaging.2017.12.005"},{"key":"2249_CR43","doi-asserted-by":"crossref","unstructured":"de Majo, Topp M, Smith SD, Nishimura AL BN, Chen H-J, Gkazi AS, et al. ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function. Neurobiol Aging. 2018;71:266.e261\u2013266.e210.","DOI":"10.1016\/j.neurobiolaging.2018.06.015"},{"key":"2249_CR44","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/humu.23161","volume":"38","author":"J Van der Zee","year":"2017","unstructured":"Van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, et al. TBK1 mutation spectrum in an extended European patient cohort with frontotemporal dementia and amyotrophic lateral sclerosis. Hum Mutat. 2017;38:297\u2013309.","journal-title":"Hum Mutat"},{"key":"2249_CR45","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neurobiolaging.2021.06.008","volume":"107","author":"Z Liu","year":"2021","unstructured":"Liu Z, Yuan Y, Wang M, Ni J, Li W, Huang L, et al. Mutation spectrum of amyotrophic lateral sclerosis in Central South China. Neurobiol Aging. 2021;107:181\u20138. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.06.008.","journal-title":"Neurobiol Aging"},{"key":"2249_CR46","doi-asserted-by":"publisher","unstructured":"Yang L, Cheng Y, Jia X, Liu X, Li X, Zhang K, et al. Four novel optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in Mainland China. Neurobiol Aging. 2021;97:149.e141\u2013149.e148. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.08.002.","DOI":"10.1016\/j.neurobiolaging.2020.08.002"},{"key":"2249_CR47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ajmg.b.31158","volume":"156B","author":"N Ticozzi","year":"2011","unstructured":"Ticozzi N, Vance C, Leclerc AL, Keagle P, Glass JD, McKenna-Yasek D, et al. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:285\u201390. https:\/\/doi.org\/10.1002\/ajmg.b.31158.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2249_CR48","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99:877\u201385.","journal-title":"Am J Hum Genet"},{"key":"2249_CR49","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/ana.25652","volume":"87","author":"J Ito","year":"2020","unstructured":"Ito J, Shimizu H, Ohta K, Idezuka J, Tanaka H, Kondo H, et al. Amyotrophic Lateral Sclerosis with Pallidonigroluysian Degeneration: A Clinicopathological Study. Ann Neurol. 2020;87:302\u201312. https:\/\/doi.org\/10.1002\/ana.25652.","journal-title":"Ann Neurol"},{"key":"2249_CR50","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/21678421.2022.2153607","volume":"24","author":"CN Fournier","year":"2023","unstructured":"Fournier CN, James V, Glass JD. Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R. Amyotroph Lateral Scler Frontotemporal Degener. 2023;24:311\u20136. https:\/\/doi.org\/10.1080\/21678421.2022.2153607.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2249_CR51","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1016\/j.jmb.2018.06.014","volume":"430","author":"PA Chong","year":"2018","unstructured":"Chong PA, Vernon RM, Forman-Kay JD. RGG\/RG motif regions in RNA binding and phase separation. J Mol Biol. 2018;430:4650\u201365.","journal-title":"J Mol Biol"},{"key":"2249_CR52","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.celrep.2018.01.031","volume":"22","author":"C Tanikawa","year":"2018","unstructured":"Tanikawa C, Ueda K, Suzuki A, Iida A, Nakamura R, Atsuta N, et al. Citrullination of RGG motifs in FET proteins by PAD4 regulates protein aggregation and ALS susceptibility. Cell Rep. 2018;22:1473\u201383.","journal-title":"Cell Rep"},{"key":"2249_CR53","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.molcel.2013.05.021","volume":"50","author":"P Thandapani","year":"2013","unstructured":"Thandapani P, O\u2019Connor TR, Bailey TL, Richard S. Defining the RGG\/RG motif. Mol Cell. 2013;50:613\u201323.","journal-title":"Mol Cell"},{"key":"2249_CR54","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41556-020-00578-6","volume":"22","author":"M-T Wei","year":"2020","unstructured":"Wei M-T, Chang Y-C, Shimobayashi SF, Shin Y, Strom AR, Brangwynne CP. Nucleated transcriptional condensates amplify gene expression. Nat cell Biol. 2020;22:1187\u201396.","journal-title":"Nat cell Biol"},{"key":"2249_CR55","doi-asserted-by":"publisher","unstructured":"Lee J, Kwon I. Phase separation of TAF15 C-terminal LC domain enables RNA-binding protein-mediated transcriptional regulation. FASEB J. 2025;39:e71126. https:\/\/doi.org\/10.1096\/fj.202502096R.","DOI":"10.1096\/fj.202502096R"},{"key":"2249_CR56","doi-asserted-by":"publisher","unstructured":"Nishiyama A, Niihori T, Warita H, Izumi R, Akiyama T, Kato M, et al. Comprehensive targeted next-generation sequencing in Japanese familial amyotrophic lateral sclerosis. Neurobiol Aging. 2017;53:194 .e191\u2013194 .e198. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.01.004.","DOI":"10.1016\/j.neurobiolaging.2017.01.004"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02249-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02249-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02249-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:08:09Z","timestamp":1790834889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02249-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":56,"alternative-id":["2249"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02249-w","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study involving human participants was approved by the ethics board of Niigata University, with the approval ID numbers G2015-0781, G2020-0031, and G2021-0010. For autopsies, including the use of tissues for research purposes, written informed consent was obtained from the families of all the patients.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}